BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 4,590.00
+60.00 (1.32%)
At close: Oct 23, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 463.19 billion as of October 23, 2026. It is the 17,110th most valuable company in the world and the 473rd biggest in South Korea. Its market cap has decreased by 17.81% in one year.
Market Cap
463.19B
Enterprise Value
98.13B
Revenue
126.41B
Global Rank
Country Rank
#473 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 463.19B, a decrease of -57.31%. That is a compound annual growth rate of -19.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 463.19B | -16.46% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SEERS | 897.28B |
| SD Biosensor | 809.82B |
| InBody Co.,Ltd | 672.67B |
| i-SENS | 475.92B |
| T&L Co., Ltd. | 416.79B |
| WON TECH | 357.34B |
| Samyang Biopharm | 328.29B |
| Curexo | 317.29B |